Meng‐Lay Lin
Queen Mary University of London(GB)Evolutionary Genomics (United States)(US)
Publications by Year
Research Areas
Cancer, Hypoxia, and Metabolism, Peroxisome Proliferator-Activated Receptors, Cancer, Lipids, and Metabolism, Epigenetics and DNA Methylation, Esophageal Cancer Research and Treatment
Most-Cited Works
- → Massive Genomic Rearrangement Acquired in a Single Catastrophic Event during Cancer Development(2011)2,417 cited
- → A comprehensive catalogue of somatic mutations from a human cancer genome(2009)1,720 cited
- → Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes(2010)1,178 cited
- → A small-cell lung cancer genome with complex signatures of tobacco exposure(2009)1,060 cited
- → Complex landscapes of somatic rearrangement in human breast cancer genomes(2009)840 cited
- → Somatic mutations of the histone H3K27 demethylase gene UTX in human cancer(2009)787 cited
- → Involvement of kinesin family member 2C/mitotic centromere‐associated kinesin overexpression in mammary carcinogenesis(2007)151 cited
- → Single-cell paired-end genome sequencing reveals structural variation per cell cycle(2013)149 cited
- → Activation of an estrogen/estrogen receptor signaling by BIG3 through its inhibitory effect on nuclear transport of PHB2/REA in breast cancer(2009)62 cited
- → LRH-1 drives colon cancer cell growth by repressing the expression of theCDKN1Agene in a p53-dependent manner(2015)59 cited